Evidence map›Paper›PMID 35110267›Full record

ArticleTurkish thoracic journal2021

High-Flow Nasal Oxygen Therapy in Acute Hypoxemic Respiratory Failure: Concise Review on Technology and Initial Methodology.

Miguel Guia, Nilgun Alpay, António Gerardo, Yasmin Madney, Mohamed Abdelrahim, Haitham Saeed, Hadeer Harb, Gil Gonçalves, Bruno Cabrita, Jaber Alqahtani and 18 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Turkish thoracic journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 20 institutions in 12 countries.

Miguel GuiaPulmonology Department, Hospital Professor Doutor Fernando Fonseca, Lisbon, Portugal.
Nilgun AlpayDepartment of Anesthesiology and Reanimation, Dentistry Faculty, Çukurova University, Adana, Turkey.
António GerardoPulmonology Department, Hospital Professor Doutor Fernando Fonseca, Lisbon, Portugal.
Yasmin MadneyClinical Pharmacy Department, Faculty of Pharmacy, Beni-suef University, Beni-suef, Egypt.
Mohamed AbdelrahimClinical Pharmacy Department, Faculty of Pharmacy, Beni-suef University, Beni-suef, Egypt.
Haitham SaeedClinical Pharmacy Department, Faculty of Pharmacy, Beni-suef University, Beni-suef, Egypt.
Hadeer HarbClinical Pharmacy Department, Faculty of Pharmacy, Beni-suef University, Beni-suef, Egypt.
Gil GonçalvesPulmonology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Bruno CabritaPulmonology Department, Hospital Pedro Hispano, Matosinhos, Portugal.
Jaber AlqahtaniDepartment of Respiratory Care, Prince Sultan Military College of Health Sciences, Dammam, Saudi Arabia.
Mohamad El-KhatibDepartment of Anesthesiology, Director of Respiratory Therapy, American University of Beirut, Beirut, Lebanon.
Manuel Gómez-RíosDepartment of Anaesthesia and Perioperative Medicine, Complejo Hospitalario Universitario de A Coruña, A Coruña, Galicia, Spain.
Atefeh FakharianChronic Respiratory Diseases Research Center (CRDRC), National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Laura CiobanuDepartment of Internal Medicine, University of Medicine and Pharmacy "Grigore T Popa", Iasi, Romania.
Habib Md Reazaul KarimDepartment of Anaesthesiology and Critical Care, All India Institute of Medical Sciences, Raipur, India.
Edoardo PiervincenziDepartment of Anesthesia and Intensive Care, Sapienza University of Rome, Rome, Italy.
Martin ScharffenbergDepartment of Anaesthesiology and Intensive Care Medicine University Hospital Carl Gustav Carus at Technische Universität Dresden, Dresden, Germany.
Paschalis SteiropoulosDepartment of Sleep Disorders Center, Vita-Salute San Raffaele University, Milan, Italy.
William LeMasterDivision of Pulmonary and Critical Care Medicine, UCLA David Geffen School of Medicine, Los Angeles, USA.
Igor BarjaktarevicDivision of Pulmonary and Critical Care Medicine, UCLA David Geffen School of Medicine, Los Angeles, USA.
Jakob WittensteinDepartment of Anaesthesiology and Intensive Care Medicine University Hospital Carl Gustav Carus at Technische Universität Dresden, Dresden, Germany.
Montserrat Diaz-AbadDivision of Pulmonary and Critical Care Medicine University of Maryland School of Medicine Baltimore, USA.
Andreas PerrenPrimario Medicina Intensiva, Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland.
Antonello NicoliniRespiratory Diseases Unit, General Hospital Sestri Levante, Sestri Levante, Italy.
Savino SpadaroDepartment Morphology, Surgery And Experimental Medicine, Intensive Care Unit, University of Ferrara, Ferrara, Italy.
Giancarlo GarutiPulmonology Unit, Santa Maria Bianca Hospital, Mirandola, Italy.
Angelo PetroianniRespiratory Diseases Unit, Respiratory Intensive Care Unit, Policlinico Umberto I Sapienza University of Rome, Italy.
Antonio EsquinasIntensive Care Unit, Hospital Morales Meseguer, Murcia, Spain.
Beni-Suef University · EGHospital Prof. Dr. Fernando Fonseca · PTUniversity Hospital Carl Gustav Carus · DEUniversity of California, Los Angeles · USUniversity of Ferrara · ITAll India Institute of Medical Sciences Raipur · INAmerican University of Beirut · LBComplexo Hospitalario Universitario A Coruña · ESCukurova University · TRGrigore T. Popa University of Medicine and Pharmacy · ROHospitais da Universidade de Coimbra · PTHospital General Universitario Morales Meseguer · ESHospital Intermutual de Levante · ESHospital Pedro Hispano · PTMasih Daneshvari Hospital · IROspedale Regionale di Bellinzona e Valli · CHPoliclinico Umberto I · ITPrince Sultan Military College of Health SciencesSanta Maria Nuova Hospital · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.

Identifiers

PMID35110267
PMCPMC8975303
OpenAlexW3214912498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.